help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on May 8, 2003, doi:10.1165/rcmb.2003-0113OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-0113OCv1
29/5/613    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Numanami, H.
Right arrow Articles by Robbins, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Numanami, H.
Right arrow Articles by Robbins, R. A.
American Journal of Respiratory Cell and Molecular Biology. Vol. 29, pp. 613-619, 2003
© 2003 American Thoracic Society
DOI: 10.1165/rcmb.2003-0113OC

Serine Protease Inhibitors Modulate Smoke-Induced Chemokine Release From Human Lung Fibroblasts

Hiroki Numanami, Sekiya Koyama, Dan K. Nelson, Jeffrey C. Hoyt, Jon L. Freels, Michael P. Habib, Jun Amano, Masayuki Haniuda, Etsuro Sato and Richard A. Robbins

Research Service, Southern Arizona Veterans Health Care System, and Arizona Respiratory Center, University of Arizona, Tucson, Arizona; First Department of Internal Medicine, and Second Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan

Address correspondence to: Richard A. Robbins, M.D., Chief, Research Service Line, Southern Arizona Veterans Health Care System, 3601 S. 6th Ave., Tucson, AZ 85723. E-mail: Richard.Robbins2{at}med.va.gov

Smoking is associated with lung inflammation and a protease–antiprotease imbalance. We previously reported that cigarette smoke extract (CSE) stimulates human lung fibroblasts to release chemotactic cytokines. We hypothesized that serine protease inhibitors might modulate lung fibroblast release of chemotactic cytokines in response to CSE. To test this hypothesis, serine protease inhibitors (FK706, {alpha}1-antitrypsin, methoxysuccinyl-Ala-Ala-Pro-Val chloromethyl ketone, or N{alpha}-p-tosyl-L-lysine chloromethyl ketone) were evaluated for their capacity to attenuate the release of neutrophil chemotactic activity (NCA) and monocyte chemotactic activity (MCA) from human fetal lung fibroblasts by the blind-well chemotactic chamber. Metalloproteinases and cysteine proteinases were not examined in this study. Similarly, the release and gene expression of chemokines and nuclear factor-{kappa}B (NF-{kappa}B) activation were measured by means of enzyme-linked immunosorbent assay and reverse transcriptase–polymerase chain reaction. Release of NCA, MCA, chemotactic chemokines including interleukin-8, granulocyte colony-stimulating factor, monocyte chemoattractant protein-1, and granulocyte-macrophage colony-stimulating factor, and the expression of interleukin-8 and monocyte chemoattractant protein-1 mRNA were attenuated by FK706. Furthermore, FK706 suppressed NF-{kappa}B activation. These data suggest that serine protease inhibitors attenuate the CSE-induced release of NCA and MCA from human fetal lung fibroblasts and that the inhibitory action of antiproteases might depend on NF-{kappa}B signaling pathway.

Abbreviations: {alpha}1-antitrypsin, {alpha}1AT • chronic obstructive pulmonary disease, COPD • cigarette smoke extract, CSE • granulocyte colony-stimulating factor, G-CSF • granulocyte-macrophage colony-stimulating factor, GM-CSF • Hanks' balanced saline solution, HBSS • human fetal lung fibroblasts, HFL-1 • high power fields, HPF • interleukin, IL • monocyte chemotactic activity, MCA • monocyte chemoattractant protein, MCP-1 • neutrophil chemotactic activity, NCA • nuclear factor-{kappa}B, NF-{kappa}B • reverse transcriptase–polymerase chain reaction, RT-PCR • methoxysuccinyl-Ala-Ala-Pro-Val chloromethyl ketone, SPCK • N{alpha}-p-tosyl-L-lysine chloromethyl ketone, TLCK




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
W. Ning, Y. Dong, J. Sun, C. Li, M. A. Matthay, C. A. Feghali-Bostwick, and A. M. K. Choi
Cigarette Smoke Stimulates Matrix Metalloproteinase-2 Activity via EGR-1 in Human Lung Fibroblasts
Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 480 - 490.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. O'Kane, J. J. Boyle, D. E. Horncastle, P. T. Elkington, and J. S. Friedland
Monocyte-Dependent Fibroblast CXCL8 Secretion Occurs in Tuberculosis and Limits Survival of Mycobacteria within Macrophages
J. Immunol., March 15, 2007; 178(6): 3767 - 3776.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. J. Baglole, S. M. Bushinsky, T. M. Garcia, A. Kode, I. Rahman, P. J. Sime, and R. P. Phipps
Differential induction of apoptosis by cigarette smoke extract in primary human lung fibroblast strains: implications for emphysema
Am J Physiol Lung Cell Mol Physiol, July 1, 2006; 291(1): L19 - L29.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. J. Walters, M. J. Paul-Clark, S. K. McMaster, K. Ito, I. M. Adcock, and J. A. Mitchell
Cigarette Smoke Activates Human Monocytes by an Oxidant-AP-1 Signaling Pathway: Implications for Steroid Resistance
Mol. Pharmacol., November 1, 2005; 68(5): 1343 - 1353.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2003 American Thoracic Society.
  2009/2010 ATS Fellows Career Development Awards